Consistent with these reports, our study also demonstrated that EZH2 enhanced the expressions of stemness-associated TF genes, SOX2, OCT4, and Nanog, as well as SUZ12 in the drug-resistant breast cancer cells. This evidence concerns the gene POU5F1 and breast carcinoma.